Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Eikon TherapeuticsEIKN | Open-market buy | 02/06 | 02/09 | 2,117,760 sh3 trades | $18.00avg. | $38,119,680 | No record | |
Eikon TherapeuticsEIKN | Open-market buy | 02/06 | 02/09 | 2,117,760 sh3 trades | $18.00avg. | $38,119,680 | No record | |
Eikon TherapeuticsEIKN | Open-market buy | 02/06 | 02/09 | 2,117,760 sh3 trades | $18.00avg. | $38,119,680 | No record | |
Eikon TherapeuticsEIKN | Open-market buy | 02/06 | 02/09 | 2,117,760 sh3 trades | $18.00avg. | $38,119,680 | No record | |
Eikon TherapeuticsEIKN | Open-market buy | 02/06 | 02/09 | 2,117,760 sh3 trades | $18.00avg. | $38,119,680 | No record | |
Eikon TherapeuticsEIKN | Open-market buy | 02/06 | 02/09 | 2,117,760 sh3 trades | $18.00avg. | $38,119,680 | No record | |
Eikon TherapeuticsEIKN | Open-market buy | 02/06 | 02/09 | 2,117,760 sh3 trades | $18.00avg. | $38,119,680 | No record | |
Eikon TherapeuticsEIKN | Open-market buy | 02/06 | 02/09 | 2,117,760 sh3 trades | $18.00avg. | $38,119,680 | No record | |
Kenneth C. FrazierDirector | Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 111,111 sh | $18.00 | $1,999,998 | No record |
Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 277,776 sh2 trades | $18.00avg. | $4,999,968 | No record | |
Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 277,776 sh2 trades | $18.00avg. | $4,999,968 | No record | |
Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 277,776 sh2 trades | $18.00avg. | $4,999,968 | No record | |
Foresite Capital Fund IV10% Owner | Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 55,555 sh | $18.00 | $999,990 | +4.4% |
Foresite Capital Management IV10% Owner | Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 55,555 sh | $18.00 | $999,990 | +4.4% |
Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 277,776 sh2 trades | $18.00avg. | $4,999,968 | No record | |
Foresite Capital Fund V10% Owner | Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 55,555 sh | $18.00 | $999,990 | +4.4% |
Foresite Capital Opportunity Fund V10% Owner | Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 55,555 sh | $18.00 | $999,990 | +4.4% |
Foresite Capital Management V10% Owner | Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 55,555 sh | $18.00 | $999,990 | +4.4% |
Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 55,555 sh | $18.00 | $999,990 | +4.4% | |
Eikon TherapeuticsEIKN | Open-market buy | 02/04 | 02/06 | 555,552 sh4 trades | $18.00avg. | $9,999,936 | No record |